logo

Merck & Co Inc. (MRK)



Trade MRK now with
  Date
  Headline
1/3/2019 6:48:10 AM Merck Says KEYTRUDA Receives Five New Approvals In Japan
1/3/2019 6:32:14 AM Merck Exercises Option For NGM Bio’ Investigational Insulin Sensitizer, NGM313, For Treatment Of NASH And Type2 Diabetes
1/2/2019 6:35:56 AM BriaCell Therapeutics Announces Imminent Clinical Use Of New Novel, Frozen Formulation For Bria-IMT
12/17/2018 6:31:18 AM Merck: EC Approves KEYTRUDA For Adjuvant Treatment Of Adults With Stage III Melanoma
12/14/2018 6:46:26 AM Merck To Acquire Privately Held Antelliq From Funds Advised By BC Partners
12/10/2018 10:02:00 AM Merck KGaA Announces FDA Orphan Drug Designation For Bifunctional Immunotherapy M7824 In Biliary Tract Cancer
12/6/2018 8:09:20 AM Merck KGaA Enters Licensing Agreement With Cyclica Inc. For Use Of Ligand Express
11/19/2018 6:32:27 AM BriaCell: Bria-IMT To Be Featured In Poster Session During 2018 San Antonio Breast Cancer Symposium